Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 162

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation

Open access
Raimondi, Lavinia, De Luca, Angela, Amodio, Nicola, Manno, Mauro, Raccosta, Samuele, Taverna, Simona, Bellavia, Daniele, Naselli, Flores, Fontana, Simona, Schillaci, Odessa, Giardino, Roberto, Fini, Milena, Tassone, Pierfrancesco, Santoro, Alessandra, De Leo, Giacomo, Giavaresi, Gianluca, Alessandro, Riccardo · 2015 · Oncotarget

Abstract

// Lavinia Raimondi 1 , Angela De Luca 1 , Nicola Amodio 2 , Mauro Manno 3 , Samuele Raccosta 3 , Simona Taverna 4 , Daniele Bellavia 1 , Flores Naselli 4 , Simona Fontana 4 , Odessa Schillaci 4 , Roberto Giardino 5 , Milena Fini 6 , Pierfrancesco Tassone 2 , Alessandra Santoro 7 , Giacomo De Leo 4 , Gianluca Giavaresi 1,6 and Riccardo Alessandro 4,8 1 Laboratory of Tissue Engineering - Innovative Technology Platforms for Tissue Engineering (PON01-00829), Rizzoli Orthopedic Institute, Palermo, Italy 2 Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy 3 Institute of Biophysics, National Research Council of Italy, Palermo, Italy 4 Section of Biology and Genetics, Department of Biopathology and Medical Biotechnology, University of Palermo, Italy 5 Rizzoli Orthopedic Institute, Bologna, Italy 6 Laboratory of Preclinical and Surgical Studies, Rizzoli Orthopedic Institute, Bologna, Italy 7 Divisione di Ematologia A.O. Ospedali Riuniti Villa Sofia-Cervello, Palermo 8 Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council of Italy, Palermo, Italy Correspondence to: Riccardo Alessandro, email: // Keywords : exosomes, multiple myeloma, osteoclasts, tumor microenvironment Received : February 02, 2015 Accepted : March 26, 2015 Published : April 12, 2015 Abstract Bone disease is the most frequent complication in multiple myeloma (MM) resulting in osteolytic lesions, bone pain, hypercalcemia and renal failure. In MM bone disease the perfect balance between bone-resorbing osteoclasts (OCs) and bone-forming osteoblasts (OBs) activity is lost in favour of OCs, thus resulting in skeletal disorders. Since exosomes have been described for their functional role in cancer progression, we here investigate whether MM cell-derived exosomes may be involved in OCs differentiation. We show that MM cells produce exosomes which are actively internalized by Raw264.7 cell line, a cellular model of osteoclast formation. MM cell-derived exosomes positively modulate pre-osteoclast migration, through the increasing of CXCR4 expression and trigger a survival pathway. MM cell-derived exosomes play a significant pro-differentiative role in murine Raw264.7 cells and human primary osteoclasts, inducing the expression of osteoclast markers such as Cathepsin K (CTSK), Matrix Metalloproteinases 9 (MMP9) and Tartrate-resistant Acid Phosphatase (TRAP). Pre-osteoclast treated with MM cell-derived exosomes differentiate in multinuclear OCs able to excavate authentic resorption lacunae. Similar results were obtained with exosomes derived from MM patient’s sera. Our data indicate that MM-exosomes modulate OCs function and differentiation. Further studies are needed to identify the OCs activating factors transported by MM cell-derived exosomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.3830

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 162

Metadata

Authors
Raimondi, L., De Luca, A., Amodio, N., Manno, M., Raccosta, S., Taverna, S., Bellavia, D., Naselli, F., Fontana, S., Schillaci, O., Giardino, R., Fini, M., Tassone, P., Santoro, A., De Leo, G., Giavaresi, G., & Alessandro, R.
Venue
Oncotarget
Published
2015-04-12
Volume
6
Issue
15
Pages
13772-13789
ISSN
1949-2553 (ISSN-L)
OpenAlex
W1488095102
Cited by
162
References
5
FWCI
7.08
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.